Giancarlo Stanton

2013 preview: Miami Marlins

23 Comments

Between now and Opening Day, HardballTalk will take a look at each of baseball’s 30 teams, asking the key questions, the not-so-key questions, and generally breaking down their chances for the 2013 season. Up next: The Miami Marlins.

The Big Question: Can the Marlins recover from their latest fire sale?

A little over a year ago, the Marlins opened up the season with a new, reinvigorated outlook. Their Opening Day payroll increased from $57.7 million in 2011 to $101.6 million thanks to three big free agent signings: Jose Reyes, Mark Buehrle, and Heath Bell. They had also acquired Carlos Zambrano, bolstering a core that included Hanley Ramirez, Josh Johnson, and Anibal Sanchez.

On July 22, the Marlins found themselves at 44-51, 12.5 games behind the first-place Washington Nationals. Feeling a second-half surge too improbable, they traded Sanchez and Omar Infante to the Detroit Tigers, then sent Hanley Ramirez to the Los Angeles Dodgers two days later. The Marlins went 25-42 the rest of the way, but they weren’t done selling.

On November 19, the Marlins and Blue Jays pulled off one of the biggest trades (in terms of number of players involved) in baseball history. The Fish sent Reyes, Johnson, Buehrle, Emilio Bonifacio, John Buck, and cash to the Toronto Blue Jays. In return, they received Yunel Escobar, Henderson Alvarez, Jeff Mathis, prospect Adeiny Hechavarria along with three other Minor Leaguers. As a result, the roster the Marlins will be opening up 2013 with looks nothing like their 2012 iteration. Those getting their first attempts at an everyday job include shortstop Hechavarria, center fielder Justin Ruggiano, second baseman Donovan Solano, and catcher Rob Brantly. Steve Cishek, with 18 career saves, will start the season as the closer.

Even for a roster that is infused with so much youth, the Marlins took some gambles as well. Logan Morrison, who can never seem to stay healthy, is taking over at first base while injury-prone 37-year-old Placido Polanco will patrol third base. 35-year-old Juan Pierre is the everyday left fielder.

Frankly, it’s tough to see what their game plan is. Despite a payroll that has shrunk below $40 million, they are not entering a rebuilding phase and they do not lay claim anything better than an average farm system, at least according to Keith Law. One year after opening up a new stadium which cost $634 million — $376.3 and $132.5 million of which was paid for by Miami-Dade County and the City of Miami, respectively – you have to wonder what, besides retaining Giancarlo Stanton, they are doing to draw fans to games.

2013 is going to be ugly in so many ways for the Marlins and what little remains of their fan base.

What else is going on? 

  • Ricky Nolasco is eligible for free agency after the season. It will be his last opportunity to strike it rich. The 30-year-old right-hander has failed to live up to lofty expectations throughout his career, owning a 4.49 ERA in over 1,100 innings. His ability to miss bats has fallen precipitously in recent years: his strikeout rate was 25 percent in 2009, but was only 15 percent last year. Don’t think the other 29 GM’s in baseball haven’t noticed because the Marlins have had ample opportunities to move him and simply couldn’t. If he can 1.) stay healthy; 2.) post good results; 3.) with an improved strikeout rate, there may be a team or two willing to pay for his services after the season.
  • How good can Giancarlo Stanton be? Dan Szymborski’s ZiPS projection system sees a .973 OPS with 41 home runs. He was at .969 with 37 dingers last year, so it is certainly realistic. That would put him around a 160 adjusted OPS. If achieved, he would join Mike Trout (2012) and Albert Pujols (2003) as the only three players in the 2000’s to post a 160 or better adjusted OPS at the age of 23 or younger. Two things to keep an eye on: 1) will the Marlins trade him, either mid-season or during the off-season? 2) will he surpass his MLB-leading (according to Hit Tracker Online) 494 feet on an August 17 home run against Josh Roenicke at Coors Field? Never forget.
  • Steve Cishek has a chance to become a decent closer. He posted a  2.63 and 2.69 ERA in 2011 and ’12, respectively, fooling hitters with a funky side-arm delivery. He still needs to work on his control – a ten percent walk rate won’t cut it in high-leverage situations over the long haul. But the potential is certainly there.
  • Ugh. Seriously, the Marlins roster as a whole is depressing and ugly with very few long-term prospects. Let’s be honest, Jeffrey Loria and David Samson are bad for baseball.

Prediction: Fifth place, National League East.

Marlins acquire starter Dan Straily from the Reds

CINCINNATI, OH - SEPTEMBER 3: Dan Straily #58 of the Cincinnati Reds throws a pitch during the first inning of the game against the St. Louis Cardinals at Great American Ball Park on September 3, 2016 in Cincinnati, Ohio. (Photo by John Sommers II/Getty Images)
Getty Images
1 Comment

The Miami Marlins have acquired starting pitcher Dan Straily from the Cincinnati Reds. In exchange, the Reds will receive right-handed pitching prospects Luis Castillo and Austin Brice and outfield prospect Isaiah White.

For the Marlins, they get a solid starter who logged 191.1 innings of 113 ERA+ ball last year. Straily has moved around a lot in his five big league seasons — the Marlins will be his fifth club in six years — but it was something of a breakout year for him in Cincinnati. The only troubling thing: he tied for the league lead in homers allowed. Of course, pitching half of his games in Great American Ballpark didn’t help that, and Miami will be a better place for him.

Castillo is 24. He split last season between high-A and Double-A — far more of it in A-ball — posting a 2.26 ERA over 24 starts. Austin Brice is also 24. He pitched 15 games in relief for the Marlins last year at the big league level with poor results. He seemed to blossom at Triple-A, however, after the Marlins shifted him to the pen. White was a third round pick in the 2015 draft. He played low-A ball as a minor leaguer last year, hitting .214/.306/.301.

A mixed bag of young talent for the Reds, but stockpiling kids and seeing what shakes out is what a team like the Reds should be doing at the moment. For the Marlins: a solid mid-to-back end starter who may just be coming into his own.

Have Hall of Fame Voters actually made the PED thing More complicated?

Sammy Sosa
Associated Press
5 Comments

The story coming out of this year’s Hall of Fame balloting is that the BBWAA voters are finally easing their antipathy toward players with performance enhancing drug associations.

Jeff Bagwell — the subject of unconfirmed PED rumors — made the Hall! Pudge Rodriguez, who was named in Jose Canseco’s book and who had a . . . curious physical transformation around the time PED testing came online, made it on the first ballot! Barry Bonds and Roger Clemens, whose PED use was well-documented, saw their vote totals advance above the 50% mark, making their future elections look more likely!

It’s an interesting development, and one I’m obviously pleased with, but I wonder if the BBWAA’s new approach to PED guys, while far more forgiving than it used to be, has actually become more complicated in practice.

I ask this because I look way, way down the ballot and I still see Sammy Sosa scraping by with around 8% of the vote. I ask this because I still see Gary Sheffield at 13%. I ask this because when Mark McGwire was on the Today’s Game ballot in December, no one really stumped for him at all. I ask this because, even though Bagwell and Mike Piazza got in eventually, they still had to go through a lot of hazing first and I suspect, if they hit the ballot for the first time again tomorrow, the same arguments and delay would occur with respect to their cases.

In light of that, what I suspect has happened has not been a wholesale surrender of the anti-PED voters. Rather, I think it has been a transformation. One in which a moral test — did he use PEDs or not? — has been discarded as a threshold question and a scientific/physiological test — would he have been great even without the PEDs? — has replaced it. In essence, voters are becoming “PED discounters” in the aggregate. Making calculations as to whether a guy was, in their mind, a creation of PEDs or not.

Such an approach explains these new voting patterns as well as those in recent years.

  • Ivan Rodriguez may have been called out by Canseco and may have noticeably shrunk over an offseason, but his calling card was his defense behind the plate and voters, I suspect, have told themselves that such a thing is not PED-aided.
  • Bonds and Clemens may have been PED users, but each of them was undeniably talented and, if you discount for the PED use, hey, they’re still all-time greats.
  • Sammy Sosa’s case rests disproportionately on homers and, as everyone knows, PEDs = instant dingers, so no, he’s not gonna cut it.

And so on.

As I said, I’m glad that the strict moral test — did he use or not? — is losing its hold on Hall voters. But I do not think the “did PEDs make him who he was test?” is a good approach either. Baseball writers are in no better a position to assess the physiological and performance enhancements caused by pharmaceuticals than they are to be judges of character and morality. Given the identities of players confirmed to be PED users, the old eye test implicit in these cases is famously faulty (Neifi Perez, anyone?). The idea that PEDs only affect home run totals — and not, say, the ability for a player to take the abuse of the catcher position for 21 seasons — is crude and ignorant.

I suppose it’s naive to expect voters to completely disregard PEDs in their assessment of players. It’s a bell that cannot be unrung. But while we may, thankfully, be moving away from a moral test with respect to drugs, it’s been displaced by a scientific test that is no more reasonable in practice.